Unknown

Dataset Information

0

Comparative proteomics reveals unexpected quantitative phosphorylation differences linked to platelet activation state.


ABSTRACT: There is a need to assess platelet activation in patients with thrombotic disorders. P-selectin and activated integrin ?IIb?3 are usually quantified by flow cytometry to measure platelet activation. Monitoring changes in vasodilator-stimulated phosphoprotein (VASP) phosphorylation is an established method to determine the platelet-reactivity status. To study disruptions of platelet reactivity more comprehensively, we compared the human non-secretory platelet proteome after in-vitro -activation and -inhibition with their respective untreated controls using unbiased fluorescence two-dimensional differential in-gel electrophoresis. The non-secretory platelet proteome was more severely affected during inhibition than during activation. Strikingly, while VASP reached a 1.3-fold increase in phosphorylation levels in inhibited platelets, other protein kinase A targets showed several-fold stronger inhibition-induced phosphorylation levels, including LIM and SH3 domain protein 1 (6.7-fold), Src kinase-associated phosphoprotein 2 (4.6-fold), and Ras-related protein Rap1b (4.1-fold). Moreover, phosphorylation of integrin-linked protein kinase (ILK) and pleckstrin (PLEK) species was associated with P-selectin surface expression. The discrimination power between activation and inhibition was more pronounced for dephosphorylated ILK (3.79 Cohen's d effect size) and phosphorylated PLEK (3.77) species than for P-selectin (2.35). These data reveal new insights into the quantitative changes of the platelet reactivity proteome and suggest powerful alternatives to characterise their activation and inactivation potential.

SUBMITTER: Schmidt GJ 

PROVIDER: S-EPMC6908631 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Comparative proteomics reveals unexpected quantitative phosphorylation differences linked to platelet activation state.

Schmidt G J GJ   Reumiller C M CM   Ercan H H   Resch U U   Butt E E   Heber S S   Liutkevičiūte Z Z   Basílio J J   Schmid J A JA   Assinger A A   Jilma B B   Zellner M M  

Scientific reports 20191212 1


There is a need to assess platelet activation in patients with thrombotic disorders. P-selectin and activated integrin αIIbβ3 are usually quantified by flow cytometry to measure platelet activation. Monitoring changes in vasodilator-stimulated phosphoprotein (VASP) phosphorylation is an established method to determine the platelet-reactivity status. To study disruptions of platelet reactivity more comprehensively, we compared the human non-secretory platelet proteome after in-vitro -activation a  ...[more]

Similar Datasets

| S-EPMC5302699 | biostudies-literature
| S-EPMC5203985 | biostudies-literature
| S-EPMC6914681 | biostudies-literature
| S-EPMC8063867 | biostudies-literature
| S-EPMC7710149 | biostudies-literature
| S-EPMC2352161 | biostudies-other
| S-EPMC4316945 | biostudies-literature
| S-EPMC4730314 | biostudies-literature